Zydus Executive and Leadership Team

Kapil Maithal, the President, Vaccines and Diagnostics at Zydus, directs the research and development pipeline for immunological products. Overseeing clinical trials and regulatory submissions, the President, Vaccines and Diagnostics ensures compliance with international safety standards across the United States and emerging markets. This leadership role involves coordinating with scientific teams to accelerate the delivery of diagnostic tools and preventative medicines. By optimizing manufacturing processes for complex biologicals, Kapil Maithal directly impacts the company's ability to address global health challenges. Furthermore, Maithal manages strategic partnerships with healthcare institutions to expand the reach of vaccine distribution. Through rigorous oversight of laboratory operations, the President, Vaccines and Diagnostics maintains the high quality of the pharmaceutical portfolio, ultimately securing the market position of the organization within the competitive biotechnology sector.

Nitinkumar Parekh, the President (Special Projects) at Zydus, manages high-priority initiatives that drive long-term organizational growth. Overseeing cross-functional teams, the President (Special Projects) ensures the successful execution of complex business transformations and infrastructure expansions. This leadership role involves analyzing market trends to identify new opportunities for pharmaceutical product development. By streamlining internal processes, Nitinkumar Parekh directly impacts the operational efficiency of the company across its global manufacturing sites. Furthermore, Parekh coordinates with the executive board to align special projects with the overarching corporate strategy. Through the implementation of advanced project management frameworks, the President (Special Projects) mitigates risks associated with large-scale investments. Ultimately, Parekh secures the competitive advantage of the organization by fostering innovation and ensuring the seamless integration of new business units into the existing pharmaceutical ecosystem.

Dr.Amrut Naik, the President at Zydus, oversees the strategic direction of core pharmaceutical operations. Managing the integration of research findings into commercial product lines, the President ensures that manufacturing output meets the rigorous demands of regulated markets in Europe and South Africa. This leadership role involves supervising the alignment of production schedules with global supply chain requirements. By optimizing resource allocation, Dr.Amrut Naik directly impacts the profitability and market penetration of the company. Furthermore, Naik collaborates with regional heads to adapt product offerings to local healthcare needs. Through the continuous monitoring of quality control metrics, the President maintains the reputation of the firm for excellence in pharmaceutical manufacturing. Ultimately, Naik drives the expansion of the product portfolio, ensuring that the organization remains at the forefront of the global pharmaceutical industry through consistent operational performance.

Rishikesh Raval, the Group President, Human Resources & Corporate Communications at Zydus, directs the talent acquisition and internal culture strategies. Overseeing global workforce development, the Group President, Human Resources & Corporate Communications ensures that the organization attracts and retains top-tier scientific and administrative talent. This leadership role involves managing corporate messaging to maintain transparency with stakeholders and the public. By fostering an environment of innovation, Rishikesh Raval directly impacts the productivity and engagement levels of the workforce across international facilities. Furthermore, Raval coordinates with leadership to align human capital strategies with the broader business objectives of the company. Through the implementation of comprehensive communication frameworks, the Group President, Human Resources & Corporate Communications strengthens the brand identity of the firm. Ultimately, Raval secures the long-term stability of the organization by building a resilient and highly skilled professional team.

Mangesh Vaze, the President, Api Business at Zydus, manages the production and distribution of active pharmaceutical ingredients. Overseeing the supply chain for raw materials, the President, Api Business ensures that manufacturing facilities maintain a steady flow of high-quality components for finished dosage forms. This leadership role involves negotiating with global suppliers to optimize costs and ensure the reliability of the production pipeline. By scaling API manufacturing capabilities, Mangesh Vaze directly impacts the company's ability to meet the demand for affordable medicines in emerging markets. Furthermore, Vaze collaborates with the research team to develop new chemical processes that enhance product efficacy. Through the rigorous application of quality assurance protocols, the President, Api Business maintains compliance with international regulatory standards. Ultimately, Vaze secures the supply chain integrity of the organization, supporting the broader mission of delivering accessible healthcare solutions worldwide.

Harish Sadana, the President Corporate Matters at Zydus, directs the legal and governance frameworks that support global operations. Overseeing compliance with international trade laws, the President Corporate Matters ensures that the company adheres to the regulatory requirements of the United States, Brazil, and other key markets. This leadership role involves managing corporate risk and protecting the intellectual property of the firm. By providing strategic guidance on legal matters, Harish Sadana directly impacts the stability and reputation of the organization. Furthermore, Sadana coordinates with the board of directors to ensure that all business activities align with ethical standards and corporate policies. Through the proactive management of legal challenges, the President Corporate Matters safeguards the assets of the company. Ultimately, Sadana secures the long-term viability of the business by maintaining a robust and transparent governance structure across all operational regions.

Kacharu Toshniwal, the President at Zydus, oversees the operational efficiency of manufacturing sites across India. Managing the transition of new products from development to full-scale production, the President ensures that facilities operate at peak capacity to meet global demand. This leadership role involves supervising the maintenance of advanced machinery and the implementation of lean manufacturing techniques. By reducing waste and improving throughput, Kacharu Toshniwal directly impacts the cost-effectiveness of the pharmaceutical production process. Furthermore, Toshniwal collaborates with the quality assurance department to ensure that every batch meets stringent safety standards. Through the oversight of regional manufacturing teams, the President maintains the consistency of the product supply chain. Ultimately, Toshniwal secures the operational excellence of the organization, ensuring that the company remains a reliable provider of essential pharmaceutical products to diverse markets around the globe.